This page requires Adobe Flash Player to display correctly.
This ticker requires Adobe Flash Player to display correctly.

Opportunities

Kinexus offers a wealth of opportunities whether you are one of our clients, suppliers, research partners, employees or investors. This section of our website provides an overview of how we can work together to advance human health and knowledge.

Employment Opportunities

Kinexus offers a wealth of opportunities whether you are one of our clients, suppliers, research partners, employees or investors. This section of our website provides an overview of how we can work together to advance human health and knowledge.

Investment Opportunities

Kinexus is still a privately held company. We are pleased to hear from individuals and institutions that may be interested in becoming shareholders of our company. If you provide us with your contact information, we would be happy to notify you of the details of future opportunities to invest in Kinexus. We recently raised $150,000 from employees in 2011 and plan to raise additional funds in 2012, as well as eventually spinout a subsidiary theranostics company.

Partnerships Opportunities

Kinexus is highly motivated to work with other companies and academic institutions in the pursuit of our corporate goals. These include the following opportunities:

Drug Development

Kinexus is seeking to forge partnerships with pharmaceutical and biotech companies that are interested in working with our company to identify appropriate protein kinase drug targets and small molecule inhibitors of these enzymes.

Diagnostics Development

We are also looking for diagnostics companies that may wish to co-develop phosphosite-based diagnostic reagents and tests. We are also willing to work with clinician scientists in universities and hospitals to investigate human samples for potential disease diagnostic biomarkers.

Bioinformatics Development

Kinexus is interested in collaborating with academic and industrial organizations with bioinformatics expertise for analysis of our KiNET databank for the purposes of signal transduction pathway mapping, and disease marker and drug target identification.

Antibody Development and Characterization

We are always open to collaborating with producers and vendors of immunological reagents to create new antibodies or for testing their existing antibody inventories for inclusion in our proteomics services.
Kinexus also enters into a small number of academic collaborative projects with university scientists each year in the pursuit of ground-breaking research. If you have an interesting proposal, send us a short 1 page outline and we will give it serious consideration.

For corporate development opportunities, please contact:

Dr. Steven Pelech
President & Chief Scientific Officer

E-mail: spelech@kinexus.ca
Phone: 604-323-2547
Credits